I'm a computational biologist whose research spans precision oncology and biodefense. The central question driving my work is how biological systems fail, adapt, and resist intervention. 

As a co-founder and chief scientific officer at NNOXX—a spin-out from the Harrington Discovery Institute at Case Western—I led the development of novel digital and molecular biosensors, taking a first-to-market technology from concept to commercialization.

Since then, my focus has been on developing computational models to understand mechanisms of treatment resistance and uncover latent therapeutic vulnerabilities in cancer — recovering the joint structure of biological systems without decomposing them into independent parts or handing their complexity to a black box. 

I also serve as a scientific advisor to early-stage health and biotechnology companies, where I provide strategic guidance across biosensor development, biological data analysis/integration, and technical due diligence. 

You can read about what I’m currently learning, working on, and thinking about on Sequence & Destroy. Additionally, you can reach me at evanpeikon@gmail.com.